Bayer Sells Carbon Nanotube and Graphene Patents

Bayer AG announced yesterday that it plans to divest itself from the fundamental IP generated through its recent research on carbon nanotubes and graphene compounds. FutureCarbon GmbH, based in Bayreuth, Germany, will acquire the bulk of the patents developed over the last 10 years.